论文部分内容阅读
据《自然》杂志报道,从事人体基因组和植物基因组顺序分析这项研究工作的日本科学家宣称,他们不打算仿效美国和英国的研究人员为自已的发现申请专利,而是将把与这些发现有关的资料公诸于世,使任何人都能够自由地利用它们。参与基因组研究的政府有关部门尚未制定出指导基因专利申请的政策;事实上,对日本政府来说,干预这类科学决策是史无前例的事。去年,美国国立卫生研究所的克雷格·温特为300多个人体基因组 DNA 片断提出了专利申请,从而在基因组研究人员出挑起了一场争论。英国医学研究理事会的研究人员最初谴责温特的这一作法,随后却改变主意,也加入了申请基因专利的行列中。迄今该理事会已对1000多个 DNA 顺序提出了专利申请。
According to the journal Nature, Japanese scientists working on the sequence analysis of the human genome and plant genomes have declared that they do not intend to follow the example of researchers in the United States and the United Kingdom applying for patents for their own discoveries. Instead, they will refer to these findings The information is made public so that anyone can freely use them. Government departments involved in genome research have yet to formulate policies that guide the patenting of genes; in fact, it is unprecedented for the Japanese government to intervene in such scientific decisions. Last year, Craig Winter, at the National Institutes of Health, filed a patent application for more than 300 pieces of human genomic DNA, triggering a debate among genomics researchers. British Medical Research Council researchers initially condemned Winter's approach, then changed his mind, but also joined the ranks of applications for genetic patents. To date, the Board has filed patent applications for more than 1,000 DNA sequences.